Featured
Novel CRISPR Base Editing Cures Sickle Cell Disease Without Bone Marrow Transplant
Duke University and NIH researchers have cured Sickle Cell Disease using in vivo CRISPR base editing delivered via a simple IV infusion. This breakthr...
Read Full Story →